Authorities have uncovered a racket involved in the manufacture as well as sale of counterfeit Mounjaro injections and arrested two individuals in connection with the case.
A nationwide alert has been issued to track these fake injections, while investigations are underway to expose the entire network and identify all those involved, Drug Control Officer Amandeep Chauhan said on Monday.
According to officials, a Health Department team conducted a raid at a residential society in Sector 62 and arrested two persons, including the alleged kingpin. The accused were reportedly importing raw drugs from China and producing counterfeit Mounjaro injections from a flat in the society. These illegal products were then sold through the B2B platform IndiaMART.
Mounjaro is a once-weekly injectable drug used to treat Type 2 diabetes, known for improving blood sugar control and aiding weight loss. “We received inputs about a fake injection network operating in Gurugram and acted swiftly on the information,” Chauhan said.
Also read: Rs 2,500-cr cyber fraud in Gujarat: Three held
Earlier, on Saturday, officials had seized injections worth around Rs 70 lakh from a vehicle in DLF Phase 4. Following this lead, the team raided the Sector 62 flat on Monday, where the injections were allegedly being prepared by mixing raw drugs with water.
Officials said that packaging, barcode labelling and sealing were also carried out within the same premises, where machines used for packing were recovered.
The first arrest was of Mujjamil, a delivery agent from DLF Phase 4. Subsequently, the alleged mastermind, Avi Sharma, was also taken into custody. Mujjamil hails from Uttar Pradesh, while Sharma is a resident of Gurugram.
Authorities have circulated batch numbers of the suspected injections across the country, urging health departments to stay alert and identify counterfeit supplies. “The probe is ongoing to trace distribution channels and determine how widespread the racket is,” Chauhan added. Experts have warned that such counterfeit drugs, often introduced to exploit rising demand, can pose serious health risks.
Follow us
